Glutathione-S-transferase (GSTM1, GSTT1) Null Phenotypes and Risk of Lung Cancer in a Korean Population

  • Piao, Jin-Mei (Department of Public Health, Qingdao University Medical College) ;
  • Shin, Min-Ho (Department of Preventive Medicine, Chonnam National University) ;
  • Kim, Hee Nam (Center for Creative Biomedical Scientists, Chonnam National University) ;
  • Cui, Lian-Hua (Department of Public Health, Qingdao University Medical College) ;
  • Song, Hye-Rim (Department of Preventive Medicine, Chonnam National University) ;
  • Kweon, Sun-Seog (Department of Preventive Medicine, Chonnam National University) ;
  • Choi, Jin-Su (Department of Preventive Medicine, Chonnam National University) ;
  • Kim, Young-Chul (Lung and Esophageal Cancer Clinic, Chonnam National University Medical School, Hwasun Hospital) ;
  • Oh, In-Jae (Lung and Esophageal Cancer Clinic, Chonnam National University Medical School, Hwasun Hospital) ;
  • Kim, Kyu-Sik (Lung and Esophageal Cancer Clinic, Chonnam National University Medical School, Hwasun Hospital)
  • Published : 2013.12.31


Purpose: The aim of this study was to evaluate any association of GSTM1 and GSTT1 null genotypes with the risk of lung cancer in a South Korean population. Methods: We conducted a large-scale, population-based case-control study including 3,933 lung cancer cases and 1,699 controls. Genotypes of GSTM1 and GSTT1 were determined using real-time polymerase chain reaction. Results: In logistic regression analysis adjusted for age and smoking, we did not find any association between GSTM1 or GSTT1 and LC risk in women. However, in men, the GSTM1 and GSTTI null genotypes were borderline associated with risk (OR=1.18, 95% CI=0.99-1.41 for GSTM1, OR=1.18, 95% CI=0.99-1.41 for GSTT1), and combined GSTM1 and GSTT1 null genotypes conferred an increased risk for LC in men (OR=1.39, 95% CI=1.08-1.78). The OR for the GSTT1 null genotype was greater in subjects aged 55 years old or younger (OR=1.45, 95% CI=1.09-1.92 for men; OR=1.36, 95% CI=0.97-1.90 for women), than in those over age 55 (OR=1.03, 95% CI=0.83-1.27 for men; OR=0.86, 95% CI=0.66-1.12 for women) in both genders (p for interaction <0.05). Conclusions: In the Korean population, the GSTM1 and GSTT1 null genotypes are risk factors for LC in men; the GSTT1 null genotype has a more prominent effect on LC risk in younger people (age 55 years and under) than in older individuals.


  1. Sorensen M, Autrup H, Tjonneland A, Overvad K, RaaschouNielsen O (2004). Glutathione S-transferase T1 nullgenotype is associated with an increased risk of lung cancer. Int J Cancer, 110, 219-24.
  2. Spitz MR, Duphorne CM, Detry MA, et al (2000). Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol Biomarkers Prev, 9, 1017-20.
  3. Stucker I, Hirvonen A, de Waziers I, et al (2002). Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility. Carcinogenesis, 23, 1475-81.
  4. Taioli E, Gaspari L, Benhamou S, et al (2003). Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years. Int J Epidemiol, 32, 60-3.
  5. To-Figueras J, Gene M, Gomez-Catalan J, et al (1997). Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms and lung cancer risk among Northwestern Mediterraneans. Carcinogenesis, 18, 1529-33.
  6. Wang LI, Giovannucci EL, Hunter D, et al (2004). Dietary intake of cruciferous vegetables, glutathione S-transferase (GST) polymorphisms and lung cancer risk in a Caucasian population. Cancer Causes Control, 15, 977-85.
  7. Zhang Y, Hua S, Zhang A, et al (2013). Association between polymorphisms in COMT, PLCH1, and CYP17A1, and non-small-cell lung cancer risk in Chinese nonsmokers. Clin Lung Cancer, 14, 45-9.
  8. Alexandrie AK, Nyberg F, Warholm M, Rannug A (2004). Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population. Cancer Epidemiol Biomarkers Prev, 13, 908-14.
  9. Bartsch H, Nair U, Risch A, et al (2000). Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev, 9, 3-28.
  10. Bell DA, Taylor JA, Paulson DF, et al (1993). Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst, 85, 1159-64.
  11. Carlsten C, Sagoo GS, Frodsham AJ, Burke W, Higgins JP (2008). Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol, 167, 759-74.
  12. Cote ML, Kardia SL, Wenzlaff AS, Land SJ, Schwartz AG (2005). Combinations of glutathione S-transferase genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study. Carcinogenesis, 26, 811-9.
  13. Cote ML, Yoo W, Wenzlaff AS, et al (2009) Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Carcinogenesis, 30, 626-35.
  14. Hayes JD, Pulford DJ (1995). The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol, 30, 445-600.
  15. Ji YN, Wang Q, Lin XQ, Suo LJ (2012). CYP1A1 MspI polymorphisms and lung cancer risk: an updated metaanalysis involving 20,209 subjects. Cytokine, 59, 324-34.
  16. Jung KW, Park S, Kong HJ, et al (2010). Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci, 25, 1113-21.
  17. Kalemkerian GP, Akerley W, Bogner P, et al (2013). Small cell lung cancer. J Natl Compr Canc Netw, 11, 78-98.
  18. Kato S, Bowman ED, Harrington AM, Blomeke B, Shields PG (1995). Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J Natl Cancer Inst, 87, 902-7.
  19. Kim HN, Lee IK, Kim YK, et al (2008). Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma. Br J Haematol, 140, 287-94.
  20. Kohno T, Kunitoh H, Shimada Y, et al (2010) Individuals susceptible to lung adenocarcinoma defined by combined HLA-DQA1 and TERT genotypes. Carcinogenesis, 31, 834-41.
  21. Kohno T, Sakiyama T, Kunitoh H, et al (2006). Association of polymorphisms in the MTH1 gene with small cell lung carcinoma risk. Carcinogenesis, 27, 2448-54.
  22. Lam TK, Ruczinski I, Helzlsouer K, et al (2009). Copy number variants of GSTM1 and GSTT1 in relation to lung cancer risk in a prospective cohort study. Ann Epidemiol, 19, 546-52.
  23. Landi S (2000) Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res, 463, 247-83.
  24. Langevin SM, Ioannidis JP, Vineis P, Taioli E (2010). Assessment of cumulative evidence for the association between glutathione S-transferase polymorphisms and lung cancer: application of the Venice interim guidelines. Pharmacogenet Genomics, 20, 586-97.
  25. Larsen JE, Colosimo ML, Yang IA, et al (2006). CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung. Carcinogenesis, 27, 525-32.
  26. Nakajima T, Elovaara E, Anttila S, et al (1995). Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer. Carcinogenesis, 16, 707-11.
  27. Nazar-Stewart V, Vaughan TL, Stapleton P, et al (2003). A population-based study of glutathione S-transferase M1, T1 and P1 genotypes and risk for lung cancer. Lung Cancer, 40, 247-58.
  28. Peto R, Darby S, Deo H, et al (2000). Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ, 321, 323-9.
  29. Piao JM, Shin MH, Kweon SS, et al (2009). Glutathione-Stransferase (GSTM1, GSTT1) and the risk of gastrointestinal cancer in a Korean population. World J Gastroenterol, 15, 5716-21.
  30. Schneider J, Bernges U, Philipp M, Woitowitz HJ (2004). GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking. Cancer Lett, 208, 65-74.
  31. Shields PG (1999) Molecular epidemiology of lung cancer. Ann Oncol, 10, S7-11.
  32. Sobin LH, Gospodarowicz M, Wittekind C (2009). TNM Classification of Malignant Tumors. 7th ed. Wiley-Liss, New York.
  33. Sobti RC, Kaur P, Kaur S, et al (2008). Combined effect of GSTM1, GSTT1 and GSTP1 polymorphisms on histological subtypes of lung cancer. Biomarkers, 13, 282-95.
  34. Sobue T, Yamamoto S, Hara M, et al (2002). Cigarette smoking and subsequent risk of lung cancer by histologic type in middle-aged Japanese men and women: the JPHC study. Int J Cancer, 99, 245-51.

Cited by

  1. Susceptibility of Lung Cancer with Polymorphisms of CYP1A1, GSTM1, GSTM3, GSTT1 and GSTP1 Genotypes in the Population of Inner Mongolia Region vol.15, pp.13, 2014,
  2. RTN4 3'-UTR Insertion/Deletion Polymorphism and Susceptibility to Non-Small Cell Lung Cancer in Chinese Han Population vol.15, pp.13, 2014,
  3. GSTM1 Polymorphisms and Lung Cancer Risk in the Chinese Population: a Meta-Analysis Based on 47 Studies vol.15, pp.18, 2014,
  4. Glutathione S-Transferase T1 and M1 Polymorphisms and Risk of Uterine Cervical Lesions in Women from Central Serbia vol.15, pp.7, 2014,
  5. Glutathione S-transferase�θ1 polymorphism contributes to lung cancer susceptibility: A meta-analysis of 26 case-control studies pp.1792-1082, 2015,
  6. CYP1A1, GSTM1, GSTT1 and TP53 Polymorphisms and Risk of Gallbladder Cancer in Bolivians vol.17, pp.2, 2016,